These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17692920)

  • 1. Repeated intermittent MDMA binges reduce DAT density in mice and SERT density in rats in reward regions of the adolescent brain.
    Kindlundh-Högberg AM; Schiöth HB; Svenningsson P
    Neurotoxicology; 2007 Nov; 28(6):1158-69. PubMed ID: 17692920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100B overexpressing mutant mice exhibit prolonged behavioural and biochemical responses towards repeated intermittent binge treatments with MDMA.
    Kindlundh-Högberg AM; Zhang X; Svenningsson P
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):201-15. PubMed ID: 18812013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice.
    Górska AM; Kamińska K; Wawrzczak-Bargieła A; Costa G; Morelli M; Przewłocki R; Kreiner G; Gołembiowska K
    Neurotox Res; 2018 Apr; 33(3):532-548. PubMed ID: 29134560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding.
    Schenk S; Hely L; Lake B; Daniela E; Gittings D; Mash DC
    Eur J Neurosci; 2007 Dec; 26(11):3229-36. PubMed ID: 18005064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
    Biezonski DK; Meyer JS
    J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period.
    Piper BJ; Meyer JS
    Pharmacol Biochem Behav; 2004 Dec; 79(4):723-31. PubMed ID: 15582680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Running wheel exercise ameliorates methamphetamine-induced damage to dopamine and serotonin terminals.
    O'Dell SJ; Galvez BA; Ball AJ; Marshall JF
    Synapse; 2012 Jan; 66(1):71-80. PubMed ID: 21953518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats.
    Piper BJ; Ali SF; Daniels LG; Meyer JS
    Synapse; 2010 Jun; 64(6):421-31. PubMed ID: 20169574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
    Camarasa J; Pubill D; Escubedo E
    Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist.
    Piper BJ; Vu HL; Safain MG; Oliver AJ; Meyer JS
    J Pharmacol Exp Ther; 2006 May; 317(2):838-49. PubMed ID: 16434566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative mapping shows that serotonin rather than dopamine receptor mRNA expressions are affected after repeated intermittent administration of MDMA in rat brain.
    Kindlundh-Högberg AM; Svenningsson P; Schiöth HB
    Neuropharmacology; 2006 Sep; 51(4):838-47. PubMed ID: 16820177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD; Miller GM; Madras BK
    Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity.
    Fone KC; Beckett SR; Topham IA; Swettenham J; Ball M; Maddocks L
    Psychopharmacology (Berl); 2002 Feb; 159(4):437-44. PubMed ID: 11823897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.
    McCann UD; Szabo Z; Vranesic M; Palermo M; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
    Psychopharmacology (Berl); 2008 Oct; 200(3):439-50. PubMed ID: 18661256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan.
    Wang X; Baumann MH; Dersch CM; Rothman RB
    Neuroscience; 2007 Aug; 148(1):212-20. PubMed ID: 17629409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDMA causes a redistribution of serotonin transporter from the cell surface to the intracellular compartment by a mechanism independent of phospho-p38-mitogen activated protein kinase activation.
    Kivell B; Day D; Bosch P; Schenk S; Miller J
    Neuroscience; 2010 Jun; 168(1):82-95. PubMed ID: 20298763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of a novel animal model of intermittent MDMA ("Ecstasy") exposure during adolescence.
    Meyer JS; Piper BJ; Vancollie VE
    Ann N Y Acad Sci; 2008 Oct; 1139():151-63. PubMed ID: 18991859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.
    Kirilly E
    Neuropsychopharmacol Hung; 2010 Sep; 12(3):413-23. PubMed ID: 20962361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.